Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. April 17, 2019. Gioia Althoff.

Executive Summary

SOPHiA GENETICS received the CE-IVD mark for its molecular diagnostic device, Solid Tumor Solution (STS). See what the company's genomics senior VP, Gioia Althoff, said about it here.

"We are currently growing our presence in the US with the hiring of talent that understand the challenges of Data-Driven Medicine adoption in order to serve the medical community the best way we can and meet the demand we face from health-care institutions in the region." –Gioia Althoff, genomics senior VP, SOPHiA GENETICS

Click here for a free trial of Medtech Insight


Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts